Myelomatous effusion with poor response to chemotherapy
Journal of Korean Medical Science
; : 243-246, 2000.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-140419
Responsible library:
WPRO
ABSTRACT
While pleural effusion in multiple myeloma is relatively infrequent, myelomatous pleural effusion is extremely rare. We experienced a 61-year-old woman with IgD-lambda multiple myeloma and pleural effusion. The diagnosis was made originally by pleural biopsy, pleural fluid cytology and immunoelectropheresis of pleural fluid. Transient improvement of the pleural effusion was observed after administration of combination chemotherapy of vincristine, melphalan, cyclophosphamide, prednisone (VMCP)/vincristine, cyclophosphamide, adriamycin, prednisone (VCAP). Two months later, myelomatous pleural effusion recurred and no response to salvage therapy was observed. We reviewed the clinical feature of this case and literature concerning myelomatous pleural effusion.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Plasma Cells
/
Pleural Effusion
/
Vincristine
/
Prednisone
/
Antineoplastic Combined Chemotherapy Protocols
/
Tomography, X-Ray Computed
/
Cyclophosphamide
/
Melphalan
/
Middle Aged
/
Multiple Myeloma
Limits:
Female
/
Humans
Language:
English
Journal:
Journal of Korean Medical Science
Year:
2000
Document type:
Article